Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
1,46 CAD | -0,68 % | -2,01 % | -18,44 % |
24/05 | Oncolytics Biotech Inc. Presenta dos resúmenes en la Reunión Anual 2024 de la Sociedad Americana de Oncología Clínica | CI |
15/05 | Transcript : Oncolytics Biotech Inc. - Shareholder/Analyst Call |
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Matthew Coffey
CEO | Chief Executive Officer | - | 11/05/11 |
Kirk Look
DFI | Director of Finance/CFO | - | 01/04/03 |
Thomas Heineman
CTO | Chief Tech/Sci/R&D Officer | - | 01/08/20 |
Jon Patton
IRC | Investor Relations Contact | - | 01/08/20 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Jonathan Rigby
BRD | Director/Board Member | 56 | 07/09/22 |
Patricia Andrews
BRD | Director/Board Member | 66 | 09/01 |
Bernd Seizinger
BRD | Director/Board Member | 67 | 08/06/15 |
James Parsons
BRD | Director/Board Member | 58 | 16/06/22 |
Angela Holtham
BRD | Director/Board Member | 73 | 18/06/14 |
Matthew Coffey
CEO | Chief Executive Officer | - | 11/05/11 |
Wayne Pisano
CHM | Chairman | 69 | 09/05/13 |
Deborah Brown
BRD | Director/Board Member | - | 02/11/17 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 75 419 768 | 72 478 872 ( 96,10 %) | 0 | 96,10 % |
Información de la empresa
Oncolytics Biotech, Inc.
322–11th Avenue SW Suite 804
T2R 0C5, Calgary
+
http://www.oncolyticsbiotech.comSector
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
-18,44 % | 81,17 M | |
+43,36 % | 54,63 mil M | |
-5,31 % | 39,92 mil M | |
+14,75 % | 26,86 mil M | |
-12,56 % | 26,22 mil M | |
-22,45 % | 18,78 mil M | |
+25,12 % | 12,21 mil M | |
+0,04 % | 12,16 mil M | |
+26,04 % | 11,94 mil M | |
-11,83 % | 10,74 mil M |
- Bolsa de valores
- Acciones
- Acción ONC
- Empresa Oncolytics Biotech Inc.